Edwards Lifesciences Corporation stock page - price, fundamentals, dividends - iOCharts

Ticker
EW

Price
97.55
Stock movement up
+4.11 (4.40%)
Company name
Edwards Lifesciences Corporation
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
60.65B
Ent value
62.20B
Price/Sales
11.32
Price/Book
10.38
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
52.09
Forward P/E
34.11
PEG
5.08
EPS growth
5.80%
1 year return
9.01%
3 year return
18.19%
5 year return
21.49%
10 year return
21.22%
Last updated: 2022-05-13

DIVIDENDS

EW does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E52.09
Price to OCF35.16
Price to FCF42.46
Price to EBITDA40.11
EV to EBITDA41.13

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales11.32
Price to Book10.38
EV to Sales11.61

FINANCIALS

Per share

Loading...
Per share data
Current share count621.75M
EPS (TTM)1.84
FCF per share (TTM)2.26

Income statement

Loading...
Income statement data
Revenue (TTM)5.36B
Gross profit (TTM)4.10B
Operating income (TTM)1.75B
Net income (TTM)1.16B
EPS (TTM)1.84
EPS (1y forward)2.86

Margins

Loading...
Margins data
Gross margin (TTM)76.58%
Operating margin (TTM)32.58%
Profit margin (TTM)21.73%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.03B
Net receivables686.20M
Total current assets3.24B
Goodwill1.17B
Intangible assets322.00M
Property, plant and equipment0.00
Total assets8.42B
Accounts payable158.80M
Short/Current long term debt688.20M
Total current liabilities949.90M
Total liabilities2.58B
Shareholder's equity5.84B
Net tangible assets4.36B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.72B
Capital expenditures (TTM)296.50M
Free cash flow (TTM)1.43B
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity19.92%
Return on Assets13.83%
Return on Invested Capital18.01%
Cash Return on Invested Capital22.10%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open95.10
Daily high98.10
Daily low95.00
Daily Volume2.52M
All-time high130.68
1y analyst estimate129.86
Beta1.15
EPS (TTM)1.84
Dividend per share-
Ex-div date-
Next earnings date27 Jul 2022

Downside potential

Loading...
Downside potential data
EWS&P500
Current price drop from All-time high-25.35%-15.91%
Highest price drop-50.47%-56.47%
Date of highest drop1 Nov 20009 Mar 2009
Avg drop from high-10.03%-11.33%
Avg time to new high14 days12 days
Max time to new high516 days1805 days
COMPANY DETAILS
EW (Edwards Lifesciences Corporation) company logo
Marketcap
60.65B
Marketcap category
Large-cap
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Employees
15700
Investor relations
SEC filings
CEO
Michael Mussallem
Country
USA
City
Irvine
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Edwards Lifesciences Corporation ( NYSE:EW ) shareholders might be concerned after seeing the share price drop 24% in...
May 10, 2022
Investors are optimistic about Edwards Lifesciences (EW) given the strong demand for its RESILIA tissue valves and the PASCAL system.
May 3, 2022
In this article, we discuss the 10 stocks that Jim Cramer says you should buy. If you want to read about some more stocks that Jim Cramer says you should buy, go directly to Jim Cramer Says You Should...
May 3, 2022
T-Mobile US, Deere, PayPal, The PNC Financial Services Group and Edwards Lifesciences have been included in this Analyst Blog.
May 2, 2022
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Deere & Company (DE), and PayPal Holdings, Inc. (PYPL).
April 29, 2022
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
April 29, 2022
IART vs. EW: Which Stock Is the Better Value Option?
April 28, 2022
The medical supplies manufacturer issues a fiscal second-quarter revenue forecast that missed analysts' estimates.
April 27, 2022
Increased adoption of the PASCAL platform along with continued strength in the HemoSphere monitoring platform drove Edwards Lifesciences' (EW) Q1 revenues.
April 27, 2022
Edwards Lifesciences Corp (NYSE: EW) posted a Q1 adjusted EPS of Q1 adjusted EPS of $0.60.60, compared to $0.54 posted a year ago and beating the consensus of $0.57. Sales increased 10% to $1.34 billi...
April 27, 2022
Next page